T Danne, J Aman, E Schober, D Deiss, JL … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Glycemic control for postprandial treatment was not worse than
preprandial treatment as assessed by fructosamine week 0 vs. 6 (mean ± SD,
preprandial 367 ± 74 vs. 378 ± 90 μmol/l; postprandial 383 ± 83 vs. 385 ... Cited by 61 - Related articles - BL Direct - All 7 versions
HB Mortensen, A Lindholm, BS Olsen, B … - European journal of pediatrics, 2000 - Springer Abstract The pharmacokinetics of the novel, rapid-acting insulin aspart were
compared with those of soluble human insulin following subcutaneous
administration in nine children (aged 6±12 years) and nine adolescents ... Cited by 68 - Related articles - BL Direct - All 4 versions
GA Brunner, S Hirschberger, G Sendlhofer, A … - Diabetic Medicine, 2000 - interscience.wiley.com Aims In intensified insulin therapy, the recent development of short-acting
insulin analogues with a very rapid onset of action forces a new discussion in
terms of the optimal injection–meal interval. This study evaluated ... Cited by 63 - Related articles - BL Direct - All 6 versions
LC Deeb, JH Holcombe, R Brunelle, S Zalani, … - Pediatrics, 2001 - pediatrics.org.p.angrylapdog.com Research Design and Methods. A 3-way crossover, open-label study involving 61
prepubertal children (ages 2.9-11.4 years) with type 1 diabetes. The children
were randomly assigned to receive regular human insulin 30 to 45 minutes ... Cited by 57 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org T Danne, RHA Becker, T Heise, C Bittner, AD … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—For insulin glulisine versus RHI, maximum insulin concentrations (58
vs. 33 μIU/ml, P < 0.05) and initial insulin concentrations (insulin [area
under the curve] AUC 0–2h 5,232 vs. 2,994 μIU · min −1 · ml −1 , P ... Cited by 46 - Related articles - BL Direct - All 7 versions
RG Bretzel, J Medding, S Hirschberger, T Linn - Age (yrs) - edge01.uniklinikum-giessen.de Page 1. INSULIN ASPART EFFICACY AND SAFETY COMPARED TO HUMAN SOLUBLE INSULIN AND
HUMAN PREMIX INSULIN (30/70) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ... Cited by 11 - Related articles - View as HTML - All 8 versions
- ►diabetesjournals.org RG Bretzel, S Arnolds, J Medding, T Linn - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 231 type 2 diabetic patients were
randomized to insulin aspart (n = 75), HI (n = 80), or MIX (n = 76) for 3
months. Insulin aspart and HI were administered with or without bedtime NPH ... Cited by 52 - Related articles - BL Direct - All 7 versions
J Colquitt, P Royle, N Waugh - Diabetic Medicine, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 60 - Related articles - BL Direct - All 4 versions
[CITATION] No increase in the duration of action with rising doses of insulin aspart
- ►diabetesjournals.org J Plank, A Wutte, G Brunner, A Siebenhofer, … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—With respect to blood glucose excursions from time 0 to 6 h (Exc
glu(0–6 h) ) and from time 0 to 4 h (Exc glu(0–4 h) ), the pharmacodynamic
effect of insulin aspart and insulin lispro can be declared equivalent. ... Cited by 76 - Related articles - BL Direct - All 6 versions
